{"nct_id":"NCT02013128","title":"Ublituximab + Ibrutinib in Select B-cell Malignancies","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2014-01-06","start_date_type":"ACTUAL","primary_completion_date":"2015-12","primary_completion_date_type":"ACTUAL","completion_date":"2015-12","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TGTX"]}